466 related articles for article (PubMed ID: 21849636)
1. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
[TBL] [Abstract][Full Text] [Related]
2. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
3. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
Hayes MR; Bradley L; Grill HJ
Endocrinology; 2009 Jun; 150(6):2654-9. PubMed ID: 19264875
[TBL] [Abstract][Full Text] [Related]
4. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM
Neurogastroenterol Motil; 2009 Sep; 21(9):978-e78. PubMed ID: 19453518
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin regulates satiation independently of the abdominal vagal nerve in a pig model of total subdiaphragmatic vagotomy.
Ripken D; van der Wielen N; van der Meulen J; Schuurman T; Witkamp RF; Hendriks HF; Koopmans SJ
Physiol Behav; 2015 Feb; 139():167-76. PubMed ID: 25449395
[TBL] [Abstract][Full Text] [Related]
6. The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.
Mietlicki-Baase EG; Ortinski PI; Rupprecht LE; Olivos DR; Alhadeff AL; Pierce RC; Hayes MR
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1367-74. PubMed ID: 24105414
[TBL] [Abstract][Full Text] [Related]
7. Vagal mediation of GLP-1's effects on food intake and glycemia.
Krieger JP; Langhans W; Lee SJ
Physiol Behav; 2015 Dec; 152(Pt B):372-80. PubMed ID: 26048300
[TBL] [Abstract][Full Text] [Related]
8. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
Steinert RE; Schirra J; Meyer-Gerspach AC; Kienle P; Fischer H; Schulte F; Goeke B; Beglinger C
Am J Clin Nutr; 2014 Aug; 100(2):514-23. PubMed ID: 24965303
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.
Vahl TP; Tauchi M; Durler TS; Elfers EE; Fernandes TM; Bitner RD; Ellis KS; Woods SC; Seeley RJ; Herman JP; D'Alessio DA
Endocrinology; 2007 Oct; 148(10):4965-73. PubMed ID: 17584962
[TBL] [Abstract][Full Text] [Related]
10. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
[TBL] [Abstract][Full Text] [Related]
11. Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.
Punjabi M; Arnold M; Rüttimann E; Graber M; Geary N; Pacheco-López G; Langhans W
Endocrinology; 2014 May; 155(5):1690-9. PubMed ID: 24601880
[TBL] [Abstract][Full Text] [Related]
12. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
Williams DL; Hyvarinen N; Lilly N; Kay K; Dossat A; Parise E; Torregrossa AM
Physiol Behav; 2011 Jul; 103(5):557-64. PubMed ID: 21515295
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
McKay NJ; Kanoski SE; Hayes MR; Daniels D
Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1755-64. PubMed ID: 21975647
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.
Basalay MV; Mastitskaya S; Mrochek A; Ackland GL; Del Arroyo AG; Sanchez J; Sjoquist PO; Pernow J; Gourine AV; Gourine A
Cardiovasc Res; 2016 Dec; 112(3):669-676. PubMed ID: 27702763
[TBL] [Abstract][Full Text] [Related]
15. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
[TBL] [Abstract][Full Text] [Related]
16. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia.
Krieger JP; Arnold M; Pettersen KG; Lossel P; Langhans W; Lee SJ
Diabetes; 2016 Jan; 65(1):34-43. PubMed ID: 26470787
[TBL] [Abstract][Full Text] [Related]
18. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation.
Mathes CM; Bueter M; Smith KR; Lutz TA; le Roux CW; Spector AC
Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(6):R751-67. PubMed ID: 22170618
[TBL] [Abstract][Full Text] [Related]
19. Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4.
Labouesse MA; Stadlbauer U; Weber E; Arnold M; Langhans W; Pacheco-López G
J Neuroendocrinol; 2012 Dec; 24(12):1505-16. PubMed ID: 22827554
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
